Test Code LI Lithium Level
Additional Codes
Cerner |
NextGen |
Lithium Level |
Lithium Level |
Alternate Name(s)
Li
Lithium carbonate
Li2CO3
Useful For
Lithium carbonate (Li2CO3) has been found to be of value in the treatment of manic-depressive psychosis (bipolar); it has a calming effect upon the manic stage and is frequently given as a therapeutic measure to forestall possible attacks.
The serum Li+ level of patients receiving this drug is usually monitored weekly during the early phase of treatment. Lithium is also measured to diagnose a potential overdose. Symptoms of lithium intoxication include sluggishness, drowsiness, muscle weakness, and ataxia.
Methodology
Colorimetric (reflectance spectrophotometry).
Patient Preparation
Samples should be drawn approximately 12 hours after the last dose of lithium.
Collection Instructions
Standard phlebotomy practices.
Specimen Requirements
Container |
|
||||||||||||
Stability |
|
||||||||||||
Rejection Criteria |
Gross Hemolysis |
Result Reporting and Reference Values
Reported in mmol/L.
Age |
Low |
High |
Critical Low |
Critical High |
12 Hour Post dose |
0.6 |
1.2 |
N/A |
1.5 |
Reflex Testing
None
Limitations
- Ortho reports a bias with the following:
- Methylparaben at 150 mg/dL has a -0.17 mmol/L bias
- N-acetylcysteine at 180 mg/dL has a -0.15 mmol/L bias
- Hemoglobin at 100 mg/dL has a +0.04 bias
- Ortho reports no significant effect with the following:
- Lipemia up to 800 mg/dL
- Bilirubin up to 40 mg/dL
- The following interpretive data is visible to the practitioner:
- N-acetylcysteine creates a negative bias of approximately 15% at the therapeutic lithium level.